Hillman Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28M Buy
187,937
+12,633
+7% +$336K 3.66% 6
2025
Q4
$4.37M Sell
175,304
-41,248
-19% -$1.04M 2.75% 13
2025
Q3
$5.52M Sell
216,552
-18,076
-8% -$446K 3.21% 9
2025
Q2
$5.69M Sell
234,628
-6,953
-3% -$162K 3.1% 11
2025
Q1
$6.12M Sell
241,581
-78,388
-24% -$2.05M 3.01% 16
2024
Q4
$8.49M Buy
319,969
+88,910
+38% +$2.41M 3.15% 10
2024
Q3
$6.69M Sell
231,059
-91
-0% -$2.65K 2.29% 23
2024
Q2
$6.47M Sell
231,150
-992
-0.4% -$27.3K 2.28% 26
2024
Q1
$6.44M Buy
232,142
+44,347
+24% +$1.23M 2.07% 30
2023
Q4
$5.41M Buy
+187,795
New +$5.68M 1.87% 35
2021
Q4
Sell
-176,532
Closed -$7.59M 58
2021
Q3
$7.59M Buy
176,532
+7,427
+4% +$329K 2.67% 22
2021
Q2
$6.62M Buy
169,105
+450
+0.3% +$17.5K 2.52% 24
2021
Q1
$6.11M Buy
168,655
+60,187
+55% +$2.14M 2.68% 23
2020
Q4
$3.99M Buy
108,468
+13,992
+15% +$513K 2.16% 29
2020
Q3
$3.29M Sell
94,476
-116
-0.1% -$4.07K 2.32% 27
2020
Q2
$2.94M Buy
94,592
+7
+0% +$238 2.14% 30
2020
Q1
$2.93M Buy
94,585
+6,358
+7% +$217K 2.81% 18
2019
Q4
$3.28M Buy
+88,227
New +$3.14M 2.32% 21
2013
Q4
$735K Hold
25,277
1.1% 34
2013
Q3
$749K Hold
25,277
1.15% 34
2013
Q2
$701K Buy
+25,277
New +$698K 0.98% 42

Other funds holding PFE

Hillman Capital Management's PFE Position: Q1 2026 in Review

Hillman Capital Management increased its Pfizer (PFE) stake by 7.2% in Q1 2026, buying an estimated $336K and bringing the position to 187,937 shares worth $5.28M. The position accounts for 3.66% of the portfolio, ranked #6.

Hillman Capital Management first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. The position peaked at $8.49M in Q4 2024. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hillman Capital Management held 187,937 shares of Pfizer worth $5.28M as of Q1 2026.
  • Hillman Capital Management bought 12,633 Pfizer shares in Q1 2026, an estimated $336K.
  • Pfizer made up 3.66% of Hillman Capital Management's portfolio in Q1 2026, its #6 holding.
  • Hillman Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
  • Hillman Capital Management's Pfizer position peaked at $8.49M in Q4 2024.
  • 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.